Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ACOG
ALPHA COGNITION INC
NASDAQ
$9.16
▼ DOWN 5.91% (-0.57)

KEY STATISTICS

Market Cap$142.27 M
52w High$10.14
52w Low$4.50
Dividend Yield—
Frequency—
P/E-7.95
Volume137.19K
Shares Out.15.53M

COMPANY

LEADERSHIP

Michael E. McFadden
CHIEF EXECUTIVE
Michael E. McFadden

COMPENSATION 2026

Salary$625,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$30,431
Total$3,624,181

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 12, 2024
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
71

PRICE TARGET

Target High$20.00
Target Low$12.00
Target Median$18.50
Target Consensus$17.25

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$7.04M
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2024-11-05Reverse1:25

PRICE

$9.16 ▼ DOWN 5.91% (−$0.57)
OVERLAYS
$9.25$9.50$9.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM9.16

About Alpha Cognition Inc

https://www.alphacognition.com ↗

Alpha Cognition Inc. is a Vancouver-based clinical-stage biopharmaceutical company developing treatments for Alzheimer's, ALS, and neurodegenerative diseases, including ZUNVEYL and gene therapies like ALPHA-0602.

INDUSTRY

Biotechnology

A PRODUCT ALPHA COGNITION INC IS KNOWN FOR

ZUNVEYL® (benzgalantamine)
ZUNVEYL® (benzgalantamine)

ZUNVEYL® is an FDA-approved oral tablet by Alpha Cognition for mild-to-moderate Alzheimer's, offering a new-generation, more tolerable acetylcholinesterase inhibitor as its primary commercial product.

COMPETITORS

COMPETITOR
AVXL COMPARE
BIIB COMPARE
JNJ COMPARE
LLY COMPARE
PFE COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Service$180.67K $140.9K ▼— —
License— — $29.98K $51.47K ▲

Revenue by Geography

MapREGIONQ1-2026
UNITED STATES$3.5M
CHINA$29.98K

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
AVSC
0.00% · 4.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
67.77%
HOLDERS
37
TOP 12 OF 37 · RANKED BY POSITION SIZE
Opaleye Management Inc.
2.6M sh · $14.07M
Solas Capital Management, LLC
2.0M sh · $12.79M
Awm Investment Company, Inc.
1.7M sh · $9.18M
Cable Car Capital LLC
1.4M sh · $7.59M
Ikarian Capital, LLC
1.1M sh · $5.8M
Sphera Funds Management Ltd.
567.6K sh · $3.12M
Alyeska Investment Group, L.P.
365.0K sh · $2M
Boothbay Fund Management, LLC
291.9K sh · $1.9M
Aristides Capital LLC
218.5K sh · $1.2M
Cantor Fitzgerald, L. P.
188.6K sh · $1.04M
Corsair Capital Management, L.P.
134.9K sh · $878.19K
Citadel Advisors LLC
118.4K sh · $769.74K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
DIRECTOR
Wills Robert James
Purchase · 10.0K shares
2026-08-21
★
10 PERCENT OWNER
Opaleye Management Inc.
Purchase · 2.9K shares
2026-07-31
★
10 PERCENT OWNER
Opaleye Management Inc.
Purchase · 50.0K shares
2026-08-03
★
10 PERCENT OWNER
Opaleye Management Inc.
Purchase · 130 shares
2026-07-24

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
MAAS$16.55COMPARE
FGBI$8.72COMPARE
CHPG$10.48COMPARE
NOEM$10.66COMPARE
SRL$5.84COMPARE
CAPN$11.18COMPARE
PROP$0.56COMPARE
YHNA$11.06COMPARE